Industry3h ago
Isomorphic Labs Secures $2.1 Billion For Drug Discovery
A $2.1 billion funding round fuels Isomorphic Labs as it deploys its new Drug Design Engine. The Google DeepMind spinoff partnered with Novartis and Eli Lilly to identify hidden drug targets. This technical approach leverages protein structure prediction to bypass traditional discovery bottlenecks. Practitioners can now track how these specific partnerships translate into clinical trials.